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HIGHLIGHTS
 Alcohol is one of the most frequently
used intoxicants in the United States.
Binge alcohol drinking is a major
contributor of emergency department
visits.
 Binge alcohol drinking may adversely
affect cardiovascular function.
 Here we show that acute alcohol
intoxication is associated with elevated
levels of cardiac endocannabinoid
anandamide and profound cardiovascular
dysfunction and blood redistribution
lasting for several hours.
 The adverse cardiovascular effects of
acute alcohol intoxication are attenuated
by CB1-R antagonist or in CB1-R knockout
mice.
 A single alcohol binge has profound effect
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SUMMARY
Excessive binge alcohol drinking may adversely affect cardiovascular function. In this study we characterize the
detailed hemodynamic effects of an acute alcohol binge in mice using multiple approaches and investigate the
role of the endocannabinoid–cannabinoid 1 receptor (CB1-R) signaling in these effects. Acute alcohol binge was
associated with elevated levels of cardiac endocannabinoid anandamide and profound cardiovascular
dysfunction lasting for several hours and redistribution of circulation. These changes were attenuated by
CB1-R antagonist or in CB1-R knockout mice. Our results suggest that a single alcohol binge has
profound effects on the cardiovascular system, which involve endocannabinoid–CB1-R signaling.
(J Am Coll Cardiol Basic Trans Science 2019;4:625–37) Published by Elsevier on behalf of the
American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A lcohol remains one of the mostfrequently used intoxicants in theUnited States, especially among
younger individuals (1,2). According to the
National Epidemiologic Survey on alcoholism and
related conditions, among 73% of human subjects
aged 18 or older who drank, 46% consumed more
than twice the number of drinks considered binge
drinking at least once in the last year (1). Binge alcohol
drinking, defined as having 4 or more drinks over 2 h
on an occasion for women, or 5 or more drinks for
men, is a major contributor of emergency department
visits in the United States (1). There is also evidence
that binge alcohol consumption can lead to develop-
ment of life-threatening or fatal conditions (3). Apart
from the severe indirect consequences, alcohol abuse
has been shown to increase the risk of atrial fibrilla-
tion, acute myocardial infarction, and congestive
heart failure to a similar degree as other well-known
risk factors (4). Despite numerous studies investi-
gating the effects of chronic moderate or excessive
alcohol consumption on cardiovascular function
and/or risk (4–10), relatively few reports have
explored the cardiovascular effects of binge ethanol
use and/or intoxication (11–17). Furthermore, these
studies primarily focused on the determination of
blood pressure or load- and/or heart rate–dependent
indices of myocardial function measured by echocar-
diography (e.g., ejection fraction [EF]). Since alcohol
is also known to time- and dose-dependently alter
vascular function, heart rate, cardiac contractility,
and peripheral resistance (10–18), reliance on load-
and heart rate-dependent indices of contractile func-
tion may lead to inaccurate conclusions.
An increasing number of high school students and
young adults have been reported to consume mari-
juana or synthetic cannabinoids [a mixture of potent
cannabinoid 1 receptor (CB1-R) agonists (19,20)] for
recreational purposes, which may induce deleterious
cardiovascular effects via CB1-R–dependent mecha-
nisms (21–23). Moreover, synthetic cannabinoids are
often consumed together with alcoholic beverages,
leading to more severe outcomes and longer hospital
stays (24). In the cardiovascular system, CB1-R is
expressed in cardiomyocytes, endothelial and smooth
muscle cells, and fibroblasts (25–28), as well as in the
peripheral and central autonomic nervous systems
(29). The effects of synthetic cannabinoids acting via
CB1-R have been well documented and may have
robust impact on the cardiovascular system, leading
to abnormalities in cardiac inotropy, chronotropy,
conduction, and vascular tone (21,29,30) [for review
see Montecucco et al. (21) and Pacher et al. (29)].
Endocannabinoids do not appear to play a significant
role in normal cardiovascular regulation, but when
overproduced in various pathologic conditions (e.g.,
various forms of shock, cardiomyopathies, or heart
failure and atherosclerosis) may contribute to hypo-
tension, decreased cardiac contractility, and/or
vascular inflammation and cell death through car-
diovascular and macrophage CB1-R [for review see
Montecucco et al. (21) and Pacher et al. (29)].
In this study, using multiple approaches and a
well-established animal model, we aimed to identify
and characterize the effects of acute alcohol intoxi-
cation on the cardiovascular system and to explore
the potential role of the endocannabinoid–CB1-R
signaling in mediating these effects. These results
ABBR EV I A T I ON S
AND ACRONYMS
2-AG = 2-arachidonyl glycerol
AEA = anandamide
CB1-R (CB1) = cannabinoid 1
receptor
CB2-R (CB2) = cannabinoid 2
receptor
dP/dtmax = maximal slope of
pressure increment
EF = ejection fraction
LV = left ventricle
MAP = mean arterial pressure
PRSW = preload recruitable
stroke work
P-V = pressure-volume
TPR = total peripheral
resistance
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may have important implications for the management
of the acute cardiovascular consequences of alcohol
and mixed alcohol-synthetic cannabinoid intoxication.
METHODS
ANIMALS. Animal handling and usage were in
accordance with the National Institutes of Health
guidelines and experimental protocols were approved
by our Institutional Animal Care and Use Committee
of the National Institute on Alcohol Abuse and Alco-
holism (Bethesda, Maryland). Eight- to 12-week-old
male and female C57BL/6J mice were used (The
Jackson Laboratory, Bar Harbor, Maine). NIAAA col-
ony of male and female Cnr1/ (CB1/) and Cnr2/
(CB2/) mice on C57BL/6J background and their
corresponding wild-type controls were also used in
this study (31,32). A total number of 198 mice were
used for the described experiments.
DRUGS. The CB1-R antagonist/inverse agonist rimo-
nabant (SR141716) was purchased from Tocris (Tocris
Bioscience, Bio-Techne, Minneapolis, Minnesota).
Drugs were dissolved in dimethyl sulfoxide:
Tocrisolve:saline solution at the ratio of 1:1:18 and
vortexed to obtain a stable emulsion for bolus intra-
venous or intraperitoneal injections (26). Rimonabant
was administered at the dose of 5 mg/kg.
EXPERIMENTAL DESIGN. In the first set of experi-
ments, a single alcohol binge (31.5% vol/vol, given at
the dose of 5 g/kg body weight) or isocaloric malto-
dextrin solution were given to mice following 12 h of
fasting as previously described (33). Cardiac function
and hemodynamics were assessed 3 or 12 h after
alcohol binge.
In the second set of experiments, the CB1-R
antagonist/inverse agonist rimonabant (5 mg/kg) or
its vehicle were administered intravenously to both
alcohol- and maltodextrin-binged mice 3 h after binge
(peak of cardiovascular effects) and hemodynamics
were assessed for at least 15 consecutive minutes
until the drug response stabilized. In other cohorts,
the acute hemodynamic effects of binge alcohol
drinking in CB1/ and CB2/ mice or in their wild-
type controls were also investigated 3 h after acute
alcohol exposure.
PRESSURE-VOLUME CATHETERIZATION AND
ECHOCARDIOGRAPHY. Left ventricular (LV) perfor-
mance was assessed by using pressure-volume (P-V)
approach (34). Briefly, a P-V catheter equippedwith a 1-
F size microtip (PVR-1045, Millar Instruments, Hous-
ton, Texas) was inserted into the right carotid artery
and advanced into the LV. Polyethylene cannulas were
also introduced into the right femoral artery and left
jugular vein to measure mean arterial pressure (MAP)
and to administer drugs, respectively. After stabiliza-
tion, P-V signals were continuously recorded by using
the PowerLab data acquisition system (ADInstruments
Inc, Colorado Springs, Colorado). Multiple indices of
load-dependent and load-independent LV function,
MAP and total peripheral resistance (TPR) were calcu-
lated as previously described (35). Echocardiography
was performed as previously reported (36).
ARTERIAL AND MICROVASCULAR BLOOD FLOW
MEASUREMENTS. Blood flow in both renal and su-
perior mesenteric arteries were measured by using
Transonic flow probes (MA0.5PSB and MA0.7PSB
perivascular flowprobes, Transonic Systems Inc.,
Ithaca, New York) and were recorded and evaluated
by using Powerlab LabChart (ADInstruments Inc.,
Colorado Springs, Colorado). Acral microcirculation was
also assessed by using the laser speckle contrast imager
moorFLPI-2 (Moor Instruments, Wilmington, Delaware).
TISSUE ENDOCANNABINOID MEASUREMENT. Myocar-
dial levels of anandamide (AEA), 2-arachidonyl
glycerol (2-AG) were quantified by liquid
chromatography/in-line mass spectrometry, as pre-
viously described (26). Values are expressed as fem-
tomoles or picomoles per milligram of wet tissue.
STATISTICAL ANALYSIS. Results are expressed as
mean  SEM and plotted as bar graphs in all figures
(see Figures 1 to 8 and Supplemental Figures 1 to 6,
except for Supplemental Figures 2B [pre-load
recruitable stroke work or PRSW], Supplemental
Figure 3A [maximal slope of pressure increment or
dP/dtmax], and Supplemental Figure 4C [TPR],
whereas data are presented as median  25th, 75th
percentiles). Statistical significance between groups
was determined by Student’s t test or in case of
multiple groups by 1-way analysis of variance fol-
lowed by Dunnett’s post hoc multiple comparison test
to compare each group to control. Equality of vari-
ances was also examined by using either F-test of the
equality of 2 variances or Brown-Forsythe test,
respectively. If populations had different distribu-
tion, nonparametric tests (Mann-Whitney test for
comparing 2 groups or Kruskal-Wallis test for multi-
ple comparisons) were applied (Supplemental
Figures 2B, 3A, and 4C) to analyze data. Statistical
significance was assessed by using GraphPad Prism 7
software (San Diego, California). Probability values of
p < 0.05 were considered significant.
RESULTS
A SINGLE ALCOHOL BINGE INDUCES CARDIAC
DYSFUNCTION AND REDISTRIBUTION OF CIRCULATION.
Alcohol binge or intoxication may adversely impact
SEE PAGE 638
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(A) Representative records of left ventricular (LV) pressure and its derivative (dP/dt) in control and alcohol-binged (EtOH 3h) mice, 3 h after
maltodextrin or alcohol administration respectively. (B) Representative pressure-volume loops of control and alcohol-binged mice. (C)
Systolic indices of LV performance [maximal slope of pressure increment (dP/dtmax), end-systolic pressure, stroke work, stroke volume, cardiac
output and ejection fraction] in control (ctrl) and alcohol-binged (EtOH 3h) mice. Data are expressed as mean  SEM, n ¼ 7 to 8; *p < 0.05
vs. control group.
Paloczi et al. J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 4 , N O . 5 , 2 0 1 9
Endocannabinoids and Binge Drinking-Induced Cardiovascular Dysfunction S E P T E M B E R 2 0 1 9 : 6 2 5 – 3 7
628
Downloaded for Anonymous User (n/a) at Washington University in Saint Louis Bernard Becker Medical Library from ClinicalKey.com by Elsevier on October 14, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
both cardiac and vascular function (see introduc-
tion); therefore, we investigated the acute effects of
alcohol binge on both load-dependent and load-
independent indices of cardiac contractility (using
echocardiography and P-V approaches) as well as on
vascular blood flow in mesenteric and renal arteries
and on skin microcirculation (using Transonic flow
probes and/or laser speckle analysis) in vivo
in mice.
In the first set of experiments, we attempted
to characterize the time course of the effect of an
acute alcohol binge on cardiovascular function and
blood redistribution (Figures 1 to 3; Supplemental
Figures 1 to 3). First, we analyzed the effects of
alcohol binge on cardiac function by
echocardiography (Supplemental Figure 1). Alcohol-
induced transient reduction of stroke volume and
cardiac output peaked around 3 h following the binge
and largely recovered after 12 h (Supplemental
Figure 1). An acute binge had no significant effect
on EF and fractional shortening measured by echo-
cardiography. Since the latter parameters could be
affected by loading conditions, which we hypothe-
sized to change by alcohol binge, we further analyzed
cardiac function using the P-V approach (35), allowing
determination of load-independent indices of LV
contractile function. In parallel, we also determined
peripheral circulation by measuring blood flow in
superior mesenteric and renal arteries of mice by
using Transonic flow probes and acral area and hin-
dlimb microcirculation by laser-speckle imaging; the
MAP and TPR were also calculated.
P-V analysis revealed marked depression of both
load-dependent (Figure 1) and load-independent
(Figure 2) indices of LV contractile function 3 h
following an acute alcohol binge, which largely
recovered by 12 h (Supplemental Figure 2). Acute
alcohol binge also induced decrease of the MAP and
TPR (Figure 3A), a consequence of decreased cardiac
function (Figures 1 and 2) and marked redistribution
of circulation (acral area and hindlimb vasodilation)
(Figure 3B), and decreased mesenteric and renal blood
flow (Figure 3C). There was no difference in the he-
modynamic response to acute alcohol binge in male
and female mice (Supplemental Figure 3).
A SINGLE ALCOHOL BINGE INCREASES MYOCARDIAL
ANANDAMIDE LEVELS. Because numerous previous
studies have shown that tissue injury and associated























































































(A) Pressure-volume (P-V) loops of control and alcohol-binged mice after gradual preload reduction obtained by vena cava inferior occlusion.
Red lines indicate the slope of end-systolic P-V relationship; blue lines display the slope of end-diastolic P-V relationship. (B) Load-
independent indices of LV performance: end-systolic elastance (Ees), the dP/dtmax-end-diastolic volume (EDV) relation and preload recruitable
stroke work (PRSW). Data are expressed as mean  SEM, n ¼ 7 to 8; *p < 0.05 vs. control group. Abbreviation as in Figure 1.
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oxidative stress and inflammation can increase
endocannabinoid levels in almost all organ systems
and cell types (including myocardium, car-
diomyocytes, activated endothelium, and inflamma-
tory cells) and that endocannabinoid–CB1-R signaling
promotes atherosclerosis and contributes to cardio-
vascular depressive state in various forms of shock,
cardiomyopathies, heart failure, and liver cirrhosis
(21,29), we hypothesized that this signaling may also
contribute to the acute cardiovascular effects of
alcohol. We found that acute alcohol binge exposure
time-dependently increased myocardial endocanna-
binoid AEA, but not 2-AG levels, peaking 3 h following
acute alcohol administration (Figure 4) when the
cardiac and vascular effects of alcohol were the most
pronounced (Figures 1 to 3). Myocardial AEA levels


















































































































































(A)Mean arterial blood pressure and total peripheral resistance measured in control and alcohol-binged (EtOH 3h) mice 3 h after maltodextrin
or alcohol administration, respectively. (B) Representative images of the jowl and hindlimb microcirculation in control and alcohol-binged
mice. Red color indicates more intense, whereas blue color represents lower microcirculation. Right panel shows data on hindlimb micro-
circulation in control and alcohol-binged mice. (C) Superior mesenteric artery and renal artery blood flow changes in control and alcohol-
binged mice. Data are expressed as mean  SEM, n ¼ 6 to 8; *p < 0.05 vs. control group. Abbreviation as in Figure 1.
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returned to baseline 9 h after alcohol ingestion
(Figure 3D) in parallel with the recovery of alcohol-
induced cardiovascular dysfunction.
CB1-R SIGNALING CONTRIBUTES TO ALCOHOL-INDUCED
ACUTE CARDIOVASCULAR EFFECTS. Because AEA is
the endocannabinoid primarily exerting its effects on
CB1-R, next we investigated the role of CB1-R
signaling in the alcohol-induced cardiovascular ef-
fects by using a CB1-R antagonist/inverse agonist
rimonabant and CB1-R knockout mice. Intravenous
administration of rimonabant rapidly improved
the 3-h alcohol intoxication-induced decrease of
MAP, TPR, and superior mesenteric and renal artery
blood flow, and attenuated the alcohol-induced pe-
ripheral vasodilation (hindlimb microcirculation)
(Figures 5A to 5C). Rimonabant also markedly
improved the alcohol binge–induced depression of
load-dependent (Figures 6A to 6C) and load-
independent (Figures 7A and 7B) indices of LV sys-
tolic function without exerting any effect in controls.
The vehicle used had no hemodynamic effects in
control or alcohol-binged groups (Supplemental
Figure 4). The marked alcohol-induced depression
of load-independent indices of LV systolic function
3 h following the alcohol binge were also largely
attenuated in CB1-R knockout mice (Figure 8).
CB1-R deletion was also associated with improved
load-dependent indices of LV contractile function
as well as better preservation of blood pressure
and TPR 3 h following an acute alcohol binge
(Supplemental Figure 5). In contrast, CB2-R
deletion had no significant effects on the
alcohol intoxication-induced cardiovascular effects
(Supplemental Figure 6). These results indicated that
endocannabinoid–CB1-R, but not CB2-R signaling
contributes to the acute hemodynamic effects of
alcohol binge.
DISCUSSION
In the present study, we characterized in detail the
binge alcohol intoxication-induced hemodynamic al-
terations (cardiac and peripheral effects) in mice
in vivo by using echocardiography, the state-of-the-
art pressure-volume catheterization, ultrasound flow
probes, and laser speckle contrast approach.
The results of the current investigation provide
several unique findings worthy of consideration. At
first, acute alcohol binge intoxication inmice induced a
profound decrease in LV contractile function accom-
panied with marked redistribution of peripheral cir-
culation leading to decreased TPR and MAP, which
peaked around 3 h following acute alcohol exposure
and recovered 12 h later. Secondly, these hemody-
namic effects were paralleled by time-dependent in-
creases in myocardial endocannabinoid AEA levels.
Thirdly, the acute inhibition of CB1-R with rimonabant
dramatically improved alcohol-induced cardiac
dysfunction, whereas this effect was widely dimin-
ished in CB1-R, but not CB2-R, knockout mice. Such
observations strongly suggest a critical role of CB1-R
activation of the peripheral vessels and the myocar-
dium inmediating a hypotensive and cardiodepressive
response to acute alcohol binge intoxication.
Heavy episodic alcohol drinking (also known as
binge drinking) is a serious health problem in the
United States (2). According to the latest surveys (1)
level I binge drinking is defined as 4 to 7 drinks for
women, and 5 to 9 drinks for men; level II as 8 to 11
drinks for women and 10 to 14 drinks for men; and
level III as 12 or more drinks for women and 15 or

















































Cardiac levels of anandamide (AEA) and 2-arachidonyl glycerol (2-AG) measured in control and alcohol-binged mice. Data are expressed as
mean  SEM, n ¼ 5 to 6; *p < 0.05 vs. control group. Abbreviations as in Figure 1.
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more drinks for men on a single occasion. Alcohol
drinking at levels II and III is considered extreme
binge drinking and is associated with increased
number of alcohol-related emergency department
visits as compared to non-binge drinkers (1).
In this study, we used a single oral administration
of an established dose of alcohol (5 g/kg) to mimic
excessive human binge drinking (33). Consistent with
previous reports using echocardiography, we found
an alcohol-induced transient reduction of stroke
volume and cardiac output with minimal effect on EF
and fractional shortening (Supplemental Figure 1).
However, under altered loading conditions, heart rate
assessment of cardiac function by using echocardi-
ography is challenging and may lead to a variety of
interpretation of the results (35). We used multiple
additional approaches including measurements of
renal and superior mesenteric arterial flow and acral
microcirculation by flow probes and/or laser speckle
imaging combined with P-V analysis and found that
excessive alcohol binge led to a profound redistribu-
tion of peripheral circulation (decreased mesenteric
and renal blood flow and increased acral microcircu-
lation) as well as a decrease in myocardial contractile
function. The alcohol-induced decrease of mesenteric
and renal blood flow can be the consequence of either
the activation of compensatory mechanisms (e.g.,
activation of the sympathetic nervous system) to
counteract the peripheral vasodilation, decrease in
blood pressure, and cardiac output; however, this can
also be the consequence of markedly reduced cardiac
output. Based on our results, the vasodilation
induced by binge alcohol exposure may ultimately
lead to alteration of loading conditions affecting
cardiac output and macrovascular function, at least in
part, via CB1-R–dependent mechanism. Furthermore,
the alcohol-induced activation of myocardial AEA–
CB1-R signaling may also decrease LV intrinsic
contractility (determined by evaluation of load- and
heart rate–independent indices of LV function)











































































































































































(A) Mean arterial blood pressure and total peripheral resistance measured after 3 h in control or in alcohol-binged mice before (ctrl base and
EtOH base, respectively) and 15 min after intravenous rimonabant (Rimo) (ctlr þ Rimo and EtOH þ Rimo, respectively) administration. (B)
Hindlimb microcirculation in control or in alcohol-binged mice before (ctrl base and EtOH base, respectively) and 15 min after intravenous
Rimo. (C) Superior mesenteric artery and renal artery blood flow changes in control and in alcohol-binged mice before the treatment (ctrl
base and EtOH base, respectively) and 15 min after intravenous Rimo (ctlr þ Rimo and EtOH þ Rimo, respectively) administration. Data are
expressed as mean  SEM, n ¼ 5 to 7; *p < 0.05 vs. corresponding control group; #p < 0.05 vs. EtOH base group. CB1-R ¼ cannabinoid 1
receptor; other abbreviations as in Figure 1.
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in vivo, further attenuating mean blood pressure and
perhaps mesenteric and renal blood flow. These he-
modynamic effects were peaking 3 h following the
alcohol exposure (not different in male and female
mice) and returned to baseline levels 12 h later.
Similarly to our results, toxic doses of alcohol
induced hypotension, decrease of TPR, and cardiac
dysfunction in dogs (13). Human studies reported
endothelial dysfunction and increases or biphasic
effects on systolic blood pressure following binge
alcohol consumption (14,16,37). In these studies, a
relatively modest dose of alcohol was used.
Similar to the effects of binge alcohol drinking,
increased endocannabinoid/CB1-R signaling has also
been implicated in the impaired cardiac contractility
associated with advanced liver cirrhosis (38,39). As
liver cirrhosis often develops on a background of
chronic alcoholism, the impairment of cardiac



















































































































































(A) Representative records of LV blood pressure changes and dP/dt in mice 3 h after either maltodextrin or alcohol binge alcohol binge
following intravenous rimonabant (Rimo) (EtOH þ Rimo) administration. (B) Representative pressure-volume (P-V) loops of maltodextrin and
alcohol-binged mice before (red and dark blue, respectively) and 15 min after intravenous Rimo (ctrl þ Rimo and EtOH þ Rimo, light green
and dark green loops, respectively) injection. (C) Systolic indices of LV performance [maximal slope of pressure increment (dP/dtmax), end-
systolic pressure, stroke work] in control and in alcohol-binged mice before (ctrl base and EtOH base, respectively) and 15 min after
intravenous Rimo (ctlr þ Rimo and EtOH þ Rimo, respectively) administration. Data are expressed as mean  SEM, n ¼ 6 to 8; *p < 0.05 vs.
corresponding control group; #p < 0.05 vs. EtOH base group. Abbreviations as in Figures 1 and 5.
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contractility may be compounded in such cases. It has
been also documented that binge alcohol drinking
induces acute myocardial injury, and increases
myocardial lipid peroxidation and protein carbonyl-
ation in mice (40). Oxidative stress has been impli-
cated in triggering endocannabinoid production in
parenchymal tissues (26,32) contributing to depres-
sion of cardiac function, vasodilation, or vasocon-
striction (26,29,41). In this study we show that acute
alcohol exposure is associated with time-dependent
increases in myocardial endocannabinoid AEA
levels, which correlate with cardiac dysfunction. We

















































































































































(A) Representative P-V loops obtained by gradual preload reduction obtained by vena cava occlusion of vehicle (veh) (ctrl þ veh and EtOH þ
veh) or Rimo (ctrl þ Rimo and EtOH þ Rimo) treated mice 3 h after either oral alcohol or maltodextrin administration, respectively. Red lines
indicate the slope of end-systolic P-V relationship, whereas blue lines depict the slope of end-diastolic P-V relationship (B) Load-independent
indices of LV performance (Ees, the dP/dtmax–end-diastolic volume (EDV) relation, and PRSW) in vehicle-treated control or alcohol-binged
mice (ctrl base, or EtOH base, respectively); or in rimonabant (Rimo)-treated control or alcohol-binged mice (ctlr þ Rimo, or EtOH þ Rimo,
respectively). Data are expressed as mean  SEM, n ¼ 5 to 6; *p < 0.05 vs. corresponding control group; #p < 0.05 vs. EtOH base group.
Abbreviations as in Figures 1, 2, 5, and 6.
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also show that intravenous administration of CB1-R
antagonist rimonabant 3 h after binge alcohol
administration (at a peak of the cardiodepressive ef-
fects) significantly improves cardiac performance as
well as redistribution of circulation, indicating an
important role of the CB1-R signaling in these path-
ologic effects, whereas rimonabant had no effects in
control mice (Figures 5 to 7). This is further substan-
tiated by the resistance of CB1-/- mice to alcohol
intoxication-induced hemodynamic effects (Figure 8).
Besides alcohol, synthetic cannabinoid abuse is an
emerging risk for youth with documented severe
adverse cardiovascular consequences mediated by
cardiovascular CB1-R (29). Synthetic cannabinoids are
often consumed together with alcoholic beverages for
recreational use, leading to more severe outcomes
(24,42).
STUDY LIMITATIONS. The in vivo study was per-
formed in mice and mice known to metabolize alcohol
faster and less sensitive to toxic effects of ethanol
compared to dogs or humans. The hemodynamic ef-
fects of alcohol intoxication are complex and most
likely also confounded by the time-dependent
activation of various compensatory mechanism (e.g.,
sympathetic nervous system). In our study we per-
formed detailed hemodynamic analysis only 3 and
12 h following the acute alcohol intoxication.
CONCLUSIONS
Collectively, we show that excessive alcohol binge
exerts complex and profound cardiovascular effects
with transient (lasting for several hours) marked
depression of myocardial contractile function. This
may represent a problem in individuals with pre-
existing cardiovascular disease, chronic alcohol con-
sumption, or regular cannabis use (29). We also show
that these hemodynamic effects involve endocanna-
binoid–CB1-R signaling, suggesting that repurposing
CB1-R antagonists for combined alcohol-synthetic
cannabinoid intoxication may save lives.
ADDRESS FOR CORRESPONDENCE: Dr. Pal Pacher,
Laboratory of Cardiovascular Physiology and Tissue
Injury, 5625 Fishers Lane, Room 2N-17, Bethesda,
Maryland 20892-9413. E-mail: pacher@mail.nih.gov.




































































































(A) Representative P-V loops of alcohol-binged CB1þ/þ and CB1-/- mice after gradual preload reduction obtained by vena cava occlusion. Red
lines indicate the slope of end-systolic P-V relationship, whereas blue lines show the slope of end-diastolic P-V relationship. (B) Load-
independent indices of LV performance (Ees, the dP/dtmax – EDV relation, and PRSW) in control or in alcohol-binged CB1
þ/þ and CB1-/- mice.
Data are expressed as mean  SEM, n ¼ 5 to 6; *p < 0.05 vs. corresponding control group; #p < 0.05 vs. alcohol-binged CB1þ/þ group.
Abbreviations as in Figures 1, 2, 5, and 6.
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